Skip to content
777 Sourcing.

Capability

high-content screening

Suppliers
3
States & provinces
2
Countries
2

3 high-content screening suppliers across 2 states and provinces in 2 countries. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ENQUBIO INC

SAN DIEGO, CA

EnquBio Inc is a San Diego-based drug R&D technology and service company (preclinical CRO) that advances pharmaceutical and biotechnology research through a comprehensive suite of drug discovery solutions. Located in San Diego's biotech hub, it operates state-of-the-art facilities led by an industry-recognized team, offering expertise in exploratory biology, high-throughput screening, SAR studies, in vitro and in vivo pharmacology, immunology-focused studies, biomarker discovery, and clinical sample analysis.

assay developmentbioanalysisbiomarker discoverycell line generationex vivo pharmacologygene expression analysisgenome editinghigh throughput screeningimmunoassayimmunophenotypingin vivo imagingin vivo pharmacologyiPSC platformnon-GLP toxicologyPK/PD analysisWestern blot

HELIGENICS, INC.

LAS VEGAS, NV

Heligenics Inc. is a biotechnology company founded in 2016 and incorporated in 2019, transforming biologic drug discovery through its proprietary GigaAssay™ technology, the first and only high-content screening platform for biologics. It screens massive biologic variant libraries in human cells to map function with MEGA-Maps™, delivering high-throughput functional insights on molecule performance in human cellular environments.

cell-based assaysDNA barcodingfunctional mappinghigh-throughput functional screeningvariant library construction

IRBM S.P.A.

POMEZIA

IRBM is a preclinical drug discovery organization based in Rome, Italy, conducting small molecule, peptide and antibody programs from target validation through to a preclinical candidate, either as a full integrated program or as a single capability for clients. Its scientists have contributed to three approved drugs and delivered more than thirty preclinical candidates to partners.

ADMEantibody phage displayassay developmentBioinformaticsbiophysical characterizationcompound managementcomputational chemistryDMPKfunctional genomicshigh throughput screeningin vivo pharmacologymedicinal chemistrymRNA displayNMRpeptide chemistrypeptide phage displayprotein productionstructural biologysynthetic chemistry

Related capabilities

Other processes offered by the shops that list high-content screening.

Browse all capabilities